CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

NewEdge Advisors, LLC's Holding History (CIK: 0001633516)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024

Shares 30 Value ($000) $1 Avg Close $46.18 Range $41.01 - $53.70

Q1 2023

Shares 60 Value ($000) $1 Avg Close $18.51 Range $15.23 - $21.65

Q4 2022

Shares 60 Value ($000) $0 Avg Close $17.62 Range $15.37 - $19.97

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2024	30	$1	$46.18	$41.01 - $53.70
Q1 2023	60	$1	$18.51	$15.23 - $21.65
Q4 2022	60	$0	$17.62	$15.37 - $19.97